You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
安旭生物(688075.SH):新型冠狀病毒(2019-nCoV)抗原自測試劑的歐盟CE認證有效期延長
格隆匯 12-03 15:43

格隆匯12月3日丨安旭生物(688075.SH)公佈,2021年11月18日,公司自主研發的新型冠狀病毒(2019-nCoV)抗原自測試劑獲得歐盟CE認證,證書有效期自2021年11月16日至2022年2月24日。

2021年12月2日,公司獲悉上述歐盟CE認證證書有效期延長至2024年5月26日。相關產品的歐盟CE認證獲得延期後可在延長期內繼續在歐盟市場進行銷售,進一步增強公司綜合實力,對公司銷售及國際業務拓展具有積極的作用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account